Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
ASX Cannabis Stocks Gain Traction on Export Quality Standards
Australian cannabis companies attract investor attention as export quality credentials differentiate ASX-listed players in global markets.
ASX Cannabis Sector Eyes Little Green Pharma's Market Leadership
LGP's performance signals broader momentum for Australian cannabis stocks as institutional focus intensifies on the emerging sector.
UK Cannabis Stocks Draw Investor Attention on FTSE AIM Exchange
Cannabis companies listed on London's junior market capture trading focus as sector dynamics shift across European markets.
UK CBD Stocks Draw Investor Attention Amid Market Volatility
British CBD companies on AIM see increased trading activity as investors reassess cannabis sector valuations following regulatory shifts across Europe.
Cannabis Stocks Pivot From Hype to Fundamentals as Investors Demand Proof
The cannabis sector faces a reality check as speculative fervor gives way to performance-based investing, forcing companies to deliver tangible results.
Canada's Cannabis Sector Left Behind in Economic Recovery Push
Despite federal promises of inclusive growth, Canada's cannabis industry faces mounting challenges that threaten its competitive position globally.
OGI Stock Faces Headwinds as Canadian Cannabis Market Matures
Organigram Holdings confronts pricing pressure and market saturation in Canada's evolving cannabis sector, testing the company's strategic positioning.
Healthcare Staffing Surge Signals Cannabis Industry Talent Demand
Healthcare staffing companies see major gains as cannabis operators compete for qualified medical professionals amid rapid industry expansion.
DEA Cannabis Hearing Set for June 29 as Legal Challenges Mount
Federal marijuana rescheduling faces dual-track pressure through administrative hearings and federal court appeals, creating regulatory uncertainty.
Healthcare Research Drives Cannabis Sector Momentum in Early 2026
Healthcare research specialists reporting strong quarterly results signal growing institutional confidence in cannabis market fundamentals.
White House Urges Hemp Protection as November Deadline Looms
Biden administration calls on Congress to prevent hemp recriminalization amid industry uncertainty over regulatory framework changes.
White House Urges Congress to Block Hemp Recriminalization Deadline
Biden administration pushes lawmakers to prevent federal hemp restrictions from taking effect in November, signaling policy support for the $7 billion industry.
DEA Hearing on Cannabis Rescheduling Advances With Witness Schedule Set
Administrative law judge finalizes testimony lineup for landmark marijuana rescheduling proceedings beginning next week, marking critical juncture for federal policy.
DEA Schedules Cannabis Rescheduling Hearing, Only Opponents Invited
Federal hearing on marijuana rescheduling begins next week with testimony limited to reform opponents under DEA administrator directive.
Canada Cannabis Lobby Dissolves as Industry Consolidation Accelerates
Major Canadian cannabis lobbying group shuts down operations, signaling broader industry maturation and shift in advocacy priorities.
DEA Rescheduling Hearing Approaches: Key Stakes for Cannabis Investors
Critical regulatory hearing could reshape federal cannabis policy and unlock institutional investment across the sector
US Territory Finally Issues First Cannabis License After 7-Year Delay
A US island territory grants its inaugural cannabis license seven years post-legalization, highlighting regulatory bottlenecks plaguing emerging markets.
Medical Tech Innovation Signals Broader Healthcare Investment Trends
AI diagnostics and oncology sectors show robust growth, highlighting investor appetite for disruptive healthcare technologies beyond traditional pharma plays.
Elite Athletes Drive Cannabis Research as Rescheduling Momentum Builds
Former Olympians pivot to cannabis research roles, highlighting shifting attitudes toward therapeutic use as federal rescheduling discussions accelerate industry legitimacy.
Michigan Medical Cannabis Revenue Plummets to $322K Amid Federal Chaos
Michigan's medical marijuana market collapses to historic lows as federal rescheduling uncertainty creates regulatory turmoil across state programs.